Portfolio company
CroíValve
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
7 investors
Sectors
About
The company develops a minimally invasive transcatheter valve system to treat tricuspid regurgitation for elderly and frail cardiac patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CroiValve
The company develops a transcatheter heart valve system to treat tricuspid regurgitation in patients unsuitable for open-heart surgery.
TRiCares
This company develops a catheter-based tricuspid valve replacement system for patients suffering from tricuspid regurgitation.
Valcare Medical
The company develops transcatheter repair and replacement technologies for heart valves to treat patients with mitral and tricuspid regurgitation.
CoreMedic
This company develops transcatheter heart valve repair systems to treat mitral valve regurgitation for patients requiring minimally invasive cardiac interventions.
Coramaze
This medical technology company develops a transcatheter valve repair system for treating patients with tricuspid regurgitation and other structural heart conditions.
Nyra Medical
The company develops a transcatheter cardiac implant to treat mitral regurgitation for patients requiring minimally invasive heart valve repair.
TRICUSPID VALVE REPAIR
Versa Vascular develops a transcatheter tricuspid valve repair system for patients suffering from tricuspid regurgitation to restore heart function without requiring open-heart surgery.
Meacor
Meacor develops a catheter-based medical device for repairing heart valves to treat patients with mitral and tricuspid regurgitation without undergoing open-heart surgery.